Alerts will be sent to your verified email
Verify Email
YANTRA
|
Yantra Natural Res
|
Stratmont Industries
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-0.02 % | 13.87 % | 27.3 % |
|
5yr average Equity Multiplier
|
1.02 | 6.09 | 1.4 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 2.84 | 1.43 |
|
5yr Avg Net Profit Margin
|
8.83 % | 1.4 % | 11.03 % |
|
Price to Book
|
0.3 | 6.56 | 0.84 |
|
P/E
|
457.14 | 143.6 | 13.7 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 92.3 Days | 154.28 Days |
|
Inventory Days
|
0.0 | 1.89 Days | 87.41 Days |
|
Days Receivable
|
0.0 | 167.03 Days | 103.86 Days |
|
Days Payable
|
673.06 Days | 286.7 Days | 63.18 Days |
|
5yr Average Interest Coverage Ratio
|
-395.5 | 366.2 | 57.05 |
|
5yr Avg ROCE
|
-0.01 % | 19.96 % | 36.52 % |
|
5yr Avg Operating Profit Margin
|
-10.68 % | -11.43 % | 16.64 % |
|
5 yr average Debt to Equity
|
0.0 | 2.19 | 0.09 |
|
5yr CAGR Net Profit
|
14.87 % | 153.17 % | -5.76 % |
|
5yr Average Return on Assets
|
-0.02 % | 4.02 % | 18.47 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 67.58 % | 65.99 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 3.04 % | -6.87 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -0.22 % | 0.0 |
|
Yantra Natural Res
|
Stratmont Industries
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|